
Dual GIP/GLP-1 receptor agonist studied in metabolic research.

AOD-9604 is a modified fragment of human growth hormone (HGH 177-191). It is studied in fat-metabolism models without the full range of growth-hormone activity.
AOD-9604 was developed to isolate a specific region of HGH for study. Research examines fat-related outcomes alongside growth and glucose markers.
Published studies use different models, routes, and schedules. The primary paper should define the concentration, handling, and study conditions.
These notes are a starting point, not a laboratory protocol or medical guidance. Check the primary sources, your institution’s procedures, and applicable regulations before planning any work.